EW

Eckard Weber

University of California: 13 patents #382 of 18,278Top 3%
CY Cytovia: 10 patents #5 of 42Top 15%
CI Cocensys, Incorporated: 9 patents #3 of 27Top 15%
UO University Of Oregon: 7 patents #3 of 170Top 2%
NP Novalar Pharmaceuticals: 7 patents #1 of 9Top 15%
OT Orexigen Therapeutics: 6 patents #3 of 12Top 25%
WC Warner-Lambert Company: 5 patents #304 of 1,610Top 20%
NP Nalpropion Pharmaceuticals: 4 patents #4 of 9Top 45%
AP Acea Pharmaceuticals: 3 patents #3 of 6Top 50%
Stanford University: 2 patents #51 of 519Top 10%
OU Oregon Health & Science University: 2 patents #224 of 725Top 35%
SO State Of Oregon: 1 patents #11 of 43Top 30%
ES Euro-Celtique S.A.: 1 patents #118 of 215Top 55%
📍 San Diego, CA: #402 of 23,606 inventorsTop 2%
🗺 California: #4,078 of 386,348 inventorsTop 2%
Overall (All Time): #27,029 of 4,157,543Top 1%
73
Patents All Time

Issued Patents All Time

Showing 51–73 of 73 patents

Patent #TitleCo-InventorsDate
5604228 Substituted guanidines having high binding to the sigma receptor and the use thereof John F. W. Keana 1997-02-18
5597922 Glycine receptor antagonist pharmacophore Sui Xiong Cai, John F. W. Keana 1997-01-28
5574070 Substituted guanidines having high binding to the sigma receptor and the use thereof John F. W. Keana 1996-11-12
5559154 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists John F. W. Keana 1996-09-24
5552443 Substituted amidines having high binding to the sigma receptor and the use thereof John F. W. Keana 1996-09-03
5514680 Glycine receptor antagonists and the use thereof John F. W. Keana 1996-05-07
5502255 Substituted guanidines having high binding to the sigma receptor and the use thereof John F. W. Keana 1996-03-26
5478863 Substituted guanidines having high binding to the sigma receptor and the use thereof John F. W. Keana 1995-12-26
5475007 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof Sui Xiong Cai, John F. W. Keana 1995-12-12
5385946 Method for treating hypertension with disubstituted granidine compounds John F. W. Keana 1995-01-31
5336689 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists John F. W. Keana 1994-08-09
5312840 Substituted guanidines having high binding to the sigma receptor and the use thereof John F. W. Keana 1994-05-17
5308869 Substituted amidines having high binding to the sigma receptor and the use thereof John F. W. Keana 1994-05-03
5262568 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists John F. W. Keana 1993-11-16
5190976 N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists John F. W. Keana 1993-03-02
5093525 N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists John F. W. Keana 1992-03-03
5011834 PCP receptor ligands and the use thereof John F. W. Keana, Peter Barmettler 1991-04-30
4975430 CNQX and its analogs as therapeutics for degenerative neural diseases Craig E. Jahr, Robin Lester 1990-12-04
4906779 N,N'-disubstituted guanidines and their use as excitatory amino acid antagonists John F. W. Keana 1990-03-06
4709094 Sigma brain receptor ligands and their use Mark Sonders, John F. W. Keana 1987-11-24
4613586 Gastrin releasing peptide-like peptides Jack D. Barchas, Christopher J. Evans, Jaw-Kang Chang, Robin G. Lorenz, Kevin Aaron Roth 1986-09-23
4587233 Use of Arg-Phe-amide derivatives Jack D. Barchas, Christopher J. Evans, E. T. Wei, J.K. Chang, Ingbert E. Fuchs +1 more 1986-05-06
4490363 Metorphamide--a novel morphine-like peptide Jack D. Barchas, Christopher J. Evans 1984-12-25